Effect of hypoalbuminemia on the increased serum cholesteryl ester transfer protein concentration in children with idiopathic nephrotic syndrome

Clinical Biochemistry

Volumn 40, Issue 12, 2007, Pages 869-875

  Zhang, Chunni ^a   Yao, Min ^a   Wang, Xiangdong ^a   Zhuang, Yiyi ^a   Xia, Zhenkun ^a   Yang, Yuhua ^b   Li, Yong ^a   Liu, Xiaozhuan ^a   Li, Ke ^a   Wang, Junjun ^a  

^a JINLING HOSPITAL   (China)

^b CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Albumin; Children; Cholesteryl ester transfer protein; Lipids; Lipoproteins; Nephrotic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; SERUM ALBUMIN; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY FUNCTION; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; REMISSION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; HUMANS; HYPOALBUMINEMIA; INFANT; KIDNEY; LIPID METABOLISM; MALE; MOLECULAR WEIGHT; NEPHROTIC SYNDROME; REGRESSION ANALYSIS; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC;

EID: 34447507920     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.04.016     Document Type: Article

References (40)

1. Tall A.R. Plasma lipid transfer protein. J. Lipid Res. 27 (1986) 361-367
2. Guerin M., Le Goff W., Lassel T.S., Van Tol A., Steiner G., and Chapman M.J. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 282-288
3. Sandhofer A., Kaser S., Ritsch A., Laimer M., Engl J., Paulweber B., et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 14 (2006) 812-818
4. Clark R.W. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors. Curr. Opin. Pharmacol. 6 (2006) 162-168
5. Forrester J.S., Makkar R., and Shah P.K. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation 111 (2005) 1847-1854
6. Ginsberg H.N., Zhang Y.L., and Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res. 36 (2005) 232-240
7. Foger B., Chase M., Amar M.J., Vaisman B.L., Shambuek R.D., Paigen B., et al. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274 (1999) 36912-36920
8. Hayek T., Masucci-Magoulas L., Jiang X., Walsh A., Rubin E., Breslow J.L., et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96 (1995) 2071-2074
9. Zhuang Y.Y., Wang J.J., Qiang H.J., Li Y., Liu X.Z., Li L.Y., et al. Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients. Clin. Chim. Acta 305 (2001) 19-25
10. Zhuang Y.Y., Wang J.J., Qiang H.J., Li Y., Liu X.Z., Li L.Y., et al. Cholesteryl ester transfer protein levels and gene deficiency in Chinese patients with cardio-cerebrovascular diseases. J. Chin. Med. 115 (2002) 371-374
11. Bagdade J.D., Ritter M.C., and Subbaiah P.V. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J. Clin. Invest. 87 (1991) 1259-1265
12. de Grooth G.J., Smilde T.J., Van Wissen S., Klerkx A.H., Zwinderman A.H., Fruchart J.C., et al. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. Atherosclerosis 173 (2004) 261-267
13. Tall A., Granot E., Brocia R., Tabas I., Hesler C., Williams K., et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J. Clin. Invest. 79 (1987) 1217-1225
14. Smaoui M., Hammami S., Attia N., Chaaba R., Abid N., Kilani N., et al. Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women. Nutr. Metab. Cardiovasc. Dis. 16 (2006) 44-53
15. de Vries R., Perton F.G., Dallinga-Thie G.M., van Roon A.M., Wolffenbuttel B.H., van Tol A., et al. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes 54 (2005) 3554-3559
16. Klerkx A.H., El Harchaoui K., van der Steeg W.A., Boekholdt S.M., Stroes E.S., Kastelein J.J., et al. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 706-715
17. Chaaba R., Hammami S., Attia N., Smaoui M., Masmoudi A.S., Mahjoub S., et al. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients. Clin. Biochem. 38 (2005) 373-378
18. van der Steeg W.A., Kuivenhoven J.A., Klerkx A.H., Boekholdt S.M., Hovingh G.K., and Kastelein J.J. Role of CETP inhibitors in the treatment of dyslipidemia. Curr. Opin. Lipidol. 15 (2004) 631-636
19. Joven J., Villabona C., Vilella E., Masana L., Alberti R., and Valles M. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N. Engl. J. Med. 323 (1990) 579-584
20. Appel G.B., Blum C.B., Chien S., Kunis C.L., and Appel A.S. The hyperlipidemia of the mephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N. Engl. J. Med. 312 (1985) 1544-1548
21. Moulin P., Appel G.B., Ginsberg H.N., and Tall A.R. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J. Lipid Res. 33 (1992) 1817-1822
22. Dullaart R.P., Gansevoort R.T., Dikkeschei B.D., de Zeeuw D., de Jong P.E., and Van Tol A. Role of elevated lecithin: cholesterol acyltansferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int. 44 (1993) 91-97
23. Subbaiah P.V., and Rodby R.A. Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome. Metabolism 43 (1994) 1126-1133
24. Braschi S., Masson D., Rostoker G., Florentin E., Athias A., Martin C., et al. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2559-2567
25. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
26. Zhuang Y.Y., Wang J.J., and Li Y. Purification and identification of cholesteryl ester transfer protein. Clin. J. Med. Lab. Sci. 22 (1999) 101-103
27. Guyard-Dangremont V., Lagrost L., Gambert P., and Lallemant C. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin. Chim. Acta 231 (1994) 146-160
28. Appel G.B., Blum C.B., Chien S.C., Kunis C.L., and Appel A.S. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N. Engl. J. Med. 312 (1985) 1544-1548
29. Waldmann T.A., Gordon Jr. R.S., and Rosse W. Studies on the metabolism of the serum proteins and lipids in a patient with analbuminemia. Am. J. Med. 37 (1964) 960-968
30. Braschi S., Lagrost L., Florentin E., Martin C., Athias A., Gambert P., et al. Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 441-449
31. Tanaka Y., Matsuyama T., Ishikura K., Hataya H., Ikeda M., and Honda M. Cholesterol ester transfer protein in children on peritoneal dialysis. Perit. Dial. Int. 24 (2004) 281-286
32. Quint E.M., Tall A.R., Ramakrishnan R., and Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J. Clin. Invest. 87 (1991) 1559-1566
33. Baldo-Enzi G., Baiocchi M.R., Vigna G., Andrian C., Mosconi C., and Fellin R. Analbuminaemia: a natural model of metabolic compensatory systems. J. Inherit. Metab. Dis. 10 (1987) 317-329
34. Braschi S., Lagrost L., Florentin E., Martin C., Athias A., Gambert P., et al. Increased cholesteryl ester transfer activity in plasma from albuminemic patients. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 441-449
35. Marcel Y.L., McPherson R., Hogue M., Czarnecka H., Zawadzki Z., Weech P.K., et al. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J. Clin. Invest. 85 (1990) 10-17
36. Alssema M., Dekker J.M., Kuivenhoven J.A., Nijpels G., Teerlink T., Scheffer P.G., et al. Elevated cholesteryl ester transfer protein concentration is associated with an increased risk for cardiovascular disease in women, but not in men, with Type 2 diabetes: the Hoorn Study. Diabet. Med. 24 (2007) 117-123
37. Marotti K.R., Castle C.K., Murray R.W., Rehberg E.F., Polites H.G., and Melchior G.W. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice. Arterioscler. Thromb. 12 (1992) 736-744
38. Hayashibe H., Asayama K., Nakane T., Uchida N., Kawada Y., and Nakazawa S. Increased plasma cholesteryl ester transfer activity in obese children. Atherosclerosis 129 (1997) 53-58
39. Kaysen G.A., Pan X.-M., Couser W.G., and Staprans I. Defective lipolysis persists in hearts of rats with heymann nephritis in the absence of nephrotic plasma. Am. J. Kidney Dis. 22 (1993) 128-134
40. Zhang C.N., Zhuang Y.Y., Qiang H.J., Liu X.Z., Xu R.J., and Wu Y.Z. Relationship between endogenous estrogen concentrations and serum cholesteryl ester transfer protein concentrations in Chinese Women. Clin. Chim. Acta 314 (2001) 77-83